Akorn, Inc.  

(Public, NASDAQ:AKRX)   Watch this stock  
Find more results for AKRX
-1.24 (-3.02%)
After Hours: 39.79 0.00 (0.00%)
Aug 31, 4:41PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 39.50 - 41.86
52 week 33.00 - 57.10
Open 41.17
Vol / Avg. 792,055.00/1.02M
Mkt cap 4.69B
P/E 122.63
Div/yield     -
EPS 0.32
Shares 114.43M
Beta 0.84
Inst. own 78%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 15.03% 6.04%
Operating margin 31.56% 17.96%
EBITD margin - 31.60%
Return on average assets 7.27% 3.07%
Return on average equity 39.15% 11.08%
Employees 1,277 -
CDP Score - -


1925 W Field Ct Ste 300
LAKE FOREST, IL 60045-4862
United States - Map
+1-847-2796100 (Phone)
+1-800-9433694 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Akorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.

Officers and directors

John N. Kapoor Ph.D. Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Rajat Rai Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Randall E Pollard Chief Accounting Officer, Interim Chief Financial Officer
Bio & Compensation  - Reuters
Bruce Kutinsky Ph.D. Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Steven Joseph Lichter Executive Vice President, Pharmaceutical Operations
Age: 56
Bio & Compensation  - Reuters
Mark M. Silverberg Executive Vice President - Global Quality Assurance and Alliance Management
Age: 60
Bio & Compensation  - Reuters
Joseph P. Bonaccorsi Senior Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
John R. Sabat Senior Vice President - National Accounts and Trade Relations
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Terry Allison Rappuhn Director
Age: 57
Bio & Compensation  - Reuters
Brian Tambi Director
Age: 70
Bio & Compensation  - Reuters